| Edwardo Torres, MD | |
|
1000 W Carson St, Box 400, Torrance, CA 90502-2004 | |
| (310) 222-2409 | |
| Not Available |
| Full Name | Edwardo Torres |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 21 Years |
| Location | 1000 W Carson St, Torrance, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417171760 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | A90084 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital - Orange County - Anahe | Anaheim, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an agreement with Ortho Biotech Oncology Research & Development, a Division of Janssen Pharmaceutica NV, for the evaluation of a novel preclinical oncology therapeutic in Champions' Biomerk Tumorgraft(TM) platform.
La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the "Company" or "La Jolla"), a biotechnology company developing therapeutics targeting significant unmet, life-threatening diseases today announced that it has completed dosing of its Phase 2 clinical trial of GCS-100 for the treatment of chronic kidney disease ("CKD") and has collected the final data for evaluation of the primary endpoint.
For the first time, researchers have access to detailed information about how an urban Aboriginal population in Canada uses health care. A new study, called Our Health Counts, uses this health database to clearly demonstrate the unique challenges faced by urban Aboriginal people in Canada - according to researchers at St. Michael's Hospital.
Black cardiac arrest victims who are stricken outside hospitals are less likely to receive bystander CPR and defibrillation on the scene than white patients, according to research that will be presented by a research team from the Perelman School of Medicine at the University of Pennsylvania today at the annual meeting of Society for Academic Emergency Medicine.
› Verified 7 days ago
| Entity Name | Newport Critical Care Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740220482 PECOS PAC ID: 1052223682 Enrollment ID: O20031103000424 |
News Archive
Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an agreement with Ortho Biotech Oncology Research & Development, a Division of Janssen Pharmaceutica NV, for the evaluation of a novel preclinical oncology therapeutic in Champions' Biomerk Tumorgraft(TM) platform.
La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the "Company" or "La Jolla"), a biotechnology company developing therapeutics targeting significant unmet, life-threatening diseases today announced that it has completed dosing of its Phase 2 clinical trial of GCS-100 for the treatment of chronic kidney disease ("CKD") and has collected the final data for evaluation of the primary endpoint.
For the first time, researchers have access to detailed information about how an urban Aboriginal population in Canada uses health care. A new study, called Our Health Counts, uses this health database to clearly demonstrate the unique challenges faced by urban Aboriginal people in Canada - according to researchers at St. Michael's Hospital.
Black cardiac arrest victims who are stricken outside hospitals are less likely to receive bystander CPR and defibrillation on the scene than white patients, according to research that will be presented by a research team from the Perelman School of Medicine at the University of Pennsylvania today at the annual meeting of Society for Academic Emergency Medicine.
› Verified 7 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an agreement with Ortho Biotech Oncology Research & Development, a Division of Janssen Pharmaceutica NV, for the evaluation of a novel preclinical oncology therapeutic in Champions' Biomerk Tumorgraft(TM) platform.
La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the "Company" or "La Jolla"), a biotechnology company developing therapeutics targeting significant unmet, life-threatening diseases today announced that it has completed dosing of its Phase 2 clinical trial of GCS-100 for the treatment of chronic kidney disease ("CKD") and has collected the final data for evaluation of the primary endpoint.
For the first time, researchers have access to detailed information about how an urban Aboriginal population in Canada uses health care. A new study, called Our Health Counts, uses this health database to clearly demonstrate the unique challenges faced by urban Aboriginal people in Canada - according to researchers at St. Michael's Hospital.
Black cardiac arrest victims who are stricken outside hospitals are less likely to receive bystander CPR and defibrillation on the scene than white patients, according to research that will be presented by a research team from the Perelman School of Medicine at the University of Pennsylvania today at the annual meeting of Society for Academic Emergency Medicine.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Edwardo Torres, MD 1000 W Carson St, Box 400, Torrance, CA 90502-2004 Ph: (310) 222-2409 | Edwardo Torres, MD 1000 W Carson St, Box 400, Torrance, CA 90502-2004 Ph: (310) 222-2409 |
News Archive
Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an agreement with Ortho Biotech Oncology Research & Development, a Division of Janssen Pharmaceutica NV, for the evaluation of a novel preclinical oncology therapeutic in Champions' Biomerk Tumorgraft(TM) platform.
La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the "Company" or "La Jolla"), a biotechnology company developing therapeutics targeting significant unmet, life-threatening diseases today announced that it has completed dosing of its Phase 2 clinical trial of GCS-100 for the treatment of chronic kidney disease ("CKD") and has collected the final data for evaluation of the primary endpoint.
For the first time, researchers have access to detailed information about how an urban Aboriginal population in Canada uses health care. A new study, called Our Health Counts, uses this health database to clearly demonstrate the unique challenges faced by urban Aboriginal people in Canada - according to researchers at St. Michael's Hospital.
Black cardiac arrest victims who are stricken outside hospitals are less likely to receive bystander CPR and defibrillation on the scene than white patients, according to research that will be presented by a research team from the Perelman School of Medicine at the University of Pennsylvania today at the annual meeting of Society for Academic Emergency Medicine.
› Verified 7 days ago
Katayoun K Mostafaie, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 21840 Normandie Ave, Ste. 700, Torrance, CA 90502 Phone: 310-222-5101 Fax: 310-320-5463 | |
Mark T. Munekata, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 21840 Normandie Ave, Ste. 700, Torrance, CA 90502 Phone: 310-222-5101 Fax: 310-320-5463 | |
Ella Ishaaya, General Practice Medicare: Not Enrolled in Medicare Practice Location: 1000 W Carson St, Torrance, CA 90502 Phone: 310-913-3890 | |
Michael Sassounian, General Practice Medicare: Medicare Enrolled Practice Location: 1000 W Carson St, Torrance, CA 90502 Phone: 310-222-2345 | |
Darrell W Harrington, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 21840 Normandie Ave, Ste. 700, Torrance, CA 90502 Phone: 310-222-5101 Fax: 310-320-5463 | |
Eric P Brass, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 21840 Normandie Ave, Torrance, CA 90502 Phone: 310-222-5101 Fax: 310-320-5463 | |
Karen W Kwan, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 1000 W Carson St, Box 480, Torrance, CA 90502 Phone: 310-222-2465 Fax: 310-328-6837 |